2000 Participants Needed

Smoking Cessation Interventions for Quitting Smoking

Recruiting at 2 trial locations
SF
Overseen BySteven Fu, MD, MSCE
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Minnesota
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This project will evaluate a proactive outreach intervention for tobacco cessation among primary care BIPOC populations who smoke in two health systems across the region. Compared with Whites, BIPOC populations in the US experience disproportionate health consequences from commercial cigarette use. Few evidence-based cessation treatments (EBCTs) have been specifically developed, evaluated, or implemented for BIPOC populations. Moreover, uptake of EBCT (e.g. medication, counseling) is lower among BIPOC populations. Reasons for the failure to engage BIPOC patients in EBCTs are complex and multi-level (e.g., patient, provider, healthcare system). To address these gaps, the investigators will assess the added effectiveness of an approach to augment the standard of care with longitudinal proactive outreach to connect BIPOC adults with EBCT. The proposed multi-level intervention leverages the electronic health record to identify patients who smoke, who can then be proactively engaged via culturally tailored outreach to connect them to EBCT. The proactive approach may circumvent experiences of bias within the healthcare system and thus enhance engagement.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Ask-Advice-Connect (AAC) for quitting smoking?

The Ask-Advice-Connect (AAC) method showed a 12.5% smoking cessation rate in a workplace program, which is above the national average, indicating its potential effectiveness. Additionally, proactive outreach strategies, like AAC, can increase access to tobacco treatment and improve quit rates by encouraging attempts among less motivated individuals.12345

Is the Ask-Advice-Connect (AAC) method safe for humans?

The Ask-Advice-Connect (AAC) method is generally considered safe for humans as it involves counseling and connecting individuals to quitlines for tobacco cessation, which are standard practices in healthcare settings. There are no reports of adverse effects related to the AAC method in the available research.12456

How is the Ask-Advice-Connect (AAC) treatment for smoking cessation different from other treatments?

The Ask-Advice-Connect (AAC) treatment is unique because it involves proactive outreach, connecting individuals directly to a quitline, which is a phone-based support service, as part of a workplace cessation program. This approach is different from traditional methods that rely on individuals to seek help themselves, and it has shown higher success rates in encouraging people to quit smoking.12457

Research Team

SF

Steven Fu, MD, MSCE

Principal Investigator

Minneapolis Veterans Affairs Medical Center

Eligibility Criteria

This trial is for BIPOC individuals who are part of the Hennepin Healthcare or MCHS system, speak English or Spanish, currently smoke cigarettes, and want to quit. They must have contact information in their health record. People with cognitive impairments or under legal guardianship, or those who've opted out of research can't participate.

Inclusion Criteria

English or Spanish-speaking BIPOC patients within the Hennepin Healthcare or MCHS system. BIPOC patients are any patients with a chart identified race that is not White, and will be verified by self-report from the baseline survey
Currently smoke more than 1 cigarette over the past 30 days
Must have address or telephone number in the electronic health record

Exclusion Criteria

I have chosen not to participate in any research studies.
My health records show I have cognitive issues or I am under legal guardianship.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive AAC plus an MI tailored outreach call at baseline and at 3, 6, and 9 months post-enrollment, with enhanced access to State Quitline and Nicotine Replacement Therapy

9 months
4 visits (virtual)

Follow-up

Participants are monitored for smoking abstinence and quality of life changes

9 months
3 visits (virtual)

Treatment Details

Interventions

  • Ask-Advice-Connect (AAC)
  • Longitudinal Proactive Outreach (LPO)
Trial Overview The study tests two methods to help BIPOC smokers quit: Ask-Advice-Connect (AAC) and Longitudinal Proactive Outreach (LPO). It aims to see if proactive outreach using these methods increases the use of evidence-based cessation treatments compared to standard care.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: AAC + Longitudinal Proactive Outreach (LPO)Experimental Treatment2 Interventions
AAC+LPO participants will receive AAC plus an MI tailored outreach call at baseline and at 3, 6, and 9 months post-enrollment. AAC includes enhanced access to State Quitline and Nicotine Replacement Therapy.
Group II: Enhanced Usual Care: Ask-Advice-Connect (AAC)Active Control1 Intervention
AAC participants will receive care through their primary care provider as usual (with the caveat that providers in the clinics will be trained to provide AAC). AAC includes enhanced access to State Quitline and Nicotine Replacement Therapy.

Ask-Advice-Connect (AAC) is already approved in United States for the following indications:

🇺🇸
Approved in United States as Ask-Advice-Connect for:
  • Tobacco cessation

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

Findings from Research

Using a local area code for proactive phone outreach significantly increased the consent rate for quitline referrals among low-income smokers, with a prevalence ratio of 1.29, indicating that familiarity may enhance engagement.
The study found that younger smokers (under 61 years) and Spanish-speaking individuals were more likely to consent to quitline referrals, suggesting that targeted outreach strategies could be particularly effective for these groups.
A Proactive Outreach Strategy Using a Local Area Code to Refer Unassisted Smokers in a Safety Net Health System to a Quitline: A Pragmatic Randomized Trial.Valencia, CV., Dove, MS., Cummins, SE., et al.[2023]
The implementation of the Ask-Advise-Connect (AAC) method in a rural Tennessee clinic led to a smoking cessation rate of 12.5% among participants, which is above the national average for smoking cessation programs.
Over a 4-month period, the clinic provided 102 counseling visits, and 21% of participants reported a significant decrease in cigarette consumption, highlighting the potential effectiveness of workplace cessation programs.
Tobacco Cessation and Referral to the National Quitline.Blocker, J., Lazear, J., Ridner, SL.[2020]
A proactive approach to smoking cessation using motivational interviewing (MI) significantly increased the number of smokers receiving counseling in hospitals, with 87% of smokers receiving intervention compared to only 22% in a reactive approach.
While the proactive strategy showed a trend towards increased smoking cessation rates at 12 months (from 43% to 51%), the difference was not statistically significant, indicating potential benefits that may require further investigation.
Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons.Auer, R., Gencer, B., Tango, R., et al.[2022]

References

A Proactive Outreach Strategy Using a Local Area Code to Refer Unassisted Smokers in a Safety Net Health System to a Quitline: A Pragmatic Randomized Trial. [2023]
Tobacco Cessation and Referral to the National Quitline. [2020]
Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons. [2022]
Proposing a Model of Proactive Outreach to Advance Clinical Research and Care Delivery for Patients Who Use Tobacco. [2023]
Workflow analysis for design of an electronic health record-based tobacco cessation intervention in community health centers. [2023]
The implementation of ask-advise-connect in a federally qualified health center: a mixed methods evaluation using the re-aim framework. [2023]
Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security